Cartesian Therapeutics, Inc. RNAC
Set alert
6.49 USD -0.26 -3.85%
At close · Oct 30
6.49 0.00 0.00%
After hours · Oct 30, 4:54 PM ET
6.44 Day range 6.76
5.84 52-week range 10.59
- YTD
- -9.99%
- 1 year
- -19.98%
- Open
- 6.72
- Prev close
- 6.75
- Mkt cap
- 196.36M
- Vol
- 78.80K
- Avg vol
- 131.43K
- EPS
- -5.78
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.44
- High
- 6.76
- Forward P/E
- -5.54
- Beta
- 0.00
- Short ratio
- 15.83
- Inst. own
- 27.85%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 20.18
- 200-d avg
- 19.88
- 1y target
- 38.17
Ownership
Held by insiders 61.39%
Held by institutions 27.85%
Float held by institutions 72.14%
Institutions 88
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 11.22% | 2,851,830 | 55.18M | Sep 29, 2024 |
| MPM BioImpact Capital LLC | 2.48% | 629,423 | 12.18M | Sep 29, 2024 |
| Siren, L.L.C. | 2.25% | 572,236 | 11.07M | Sep 29, 2024 |
| Blackrock Inc. | 1.67% | 423,466 | 8.19M | Sep 29, 2024 |
| Citadel Advisors Llc | 1.48% | 375,767 | 7.27M | Sep 29, 2024 |
| JP Morgan Chase & Company | 1.22% | 309,018 | 5.98M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Select Portfolios - Biotechnology | 3.69% | 936,691 | 18.12M | Oct 30, 2024 |
| Fidelity Select Portfolios - Health Care | 1.45% | 368,992 | 7.14M | Oct 30, 2024 |
| Fidelity Growth Company Fund | 1.34% | 341,346 | 6.61M | Oct 30, 2024 |
| Fidelity Advisor Health Care Fund | 0.91% | 230,254 | 4.46M | Oct 30, 2024 |
| iShares Russell 2000 ETF | 0.70% | 177,734 | 3.44M | Oct 30, 2024 |
| Fidelity Advisor Biotechnology Fund | 0.66% | 167,950 | 3.25M | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARABE TIMOTHY CRAIG | Director | Purchase | Aug 11, 2024 | 21,766 |
| HOGE ELIZABETH | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Oct 10, 2024 | 0 |
| JEWELL CHRISTOPHER M | Officer | Conversion of Exercise of derivative security | Nov 19, 2024 | 39,940 |
| KALAYOGLU MURAT | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Oct 10, 2024 | 0 |
| KURTOGLU METIN | Chief Technology Officer | Conversion of Exercise of derivative security | Dec 9, 2024 | 51,033 |
| MALIK KEMAL | Director | Stock Award(Grant) | Jun 30, 2024 | 5,933 |
Held by funds
45 US ETFs and mutual funds hold RNAC · largest positions